IP Verse

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity

Patent No. EP3153526 (titled "Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity") was filed by Inserm Institut National DE LA Sant ET DE LA Recherche Mdicale on Jan 30, 2009. The application was issued on Sep 23, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTJun 23, 2021BOULT WADE TENNANT
TRISHULA THERAPEUTICSJun 23, 2021HUTTER
ABBVIEJun 21, 2021MEWBURN ELLIS
SURFACE ONCOLOGYJun 21, 2021HOIBERG PS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3153526

INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE
Application Number
EP16198909A
Filing Date
Jan 30, 2009
Status
Granted And Under Opposition
Aug 21, 2020
Publication Date
Sep 23, 2020
External Links
Slate, Register , Google Patents